Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cipla
US Department of Justice
Chinese Patent Office
Cantor Fitzgerald
AstraZeneca
Moodys
Citi
QuintilesIMS
Express Scripts

Generated: December 10, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,906,086

« Back to Dashboard

Summary for Patent: 6,906,086

Title: Methods for inhibiting bone loss
Abstract:The current invention provides methods and pharmaceutical formulations that are useful for inhibiting the loss of bone. These methods and formulations can be used without the associated adverse effects of estrogen therapy, and thus serve as an effective and acceptable treatment for osteoporosis.
Inventor(s): Black; Larry J. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:10/446,210
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

International Patent Family for Patent: 6,906,086

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain2283939► Subscribe
New Zealand504611► Subscribe
New Zealand314686► Subscribe
Czech Republic9301498► Subscribe
Cyprus2044► Subscribe
Cyprus2599► Subscribe
Czech Republic281913► Subscribe
Germany19975012► Subscribe
Germany69310288► Subscribe
Germany69334132► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
McKinsey
Moodys
Chinese Patent Office
AstraZeneca
Boehringer Ingelheim
Cerilliant
Colorcon
Covington
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot